Trial Profile
Study on Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Feb 2019
Price :
$35
*
At a glance
- Drugs Levodopa/carbidopa (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms ADEQUA
- Sponsors AbbVie
- 09 Oct 2018 Results presented at the 22nd International Congress of Parkinson's Disease and Movement Disorders
- 19 Jun 2018 Results of a subgroup post hoc analysis (n=59) presented at the 4th Congress of the European Academy of Neurology
- 07 Dec 2016 Status changed from active, no longer recruiting to completed.